Johnson & Johnson

JNJU.S.: NYSE

Quote

$114.64

0.04 (0.035%)

After Hours Vol 317.9K

Jan 13, 2017 ESTComprehensive quote

$114.60

-0.02 (-0.017%)

Jan 13, 2017 EST

Volume	4.6M
Avg Vol (65d)	7.2M
Open	$114.94
Day Range	$114.44 - $115.02
52 Wk Range	$94.28 - $126.07
Market Value	$311.8B
Ytd net Change	-0.5%
1 Yr net Change	18.1%
P/E Ratio(TTM)	20.28
EPS(TTM)	$5.65
Div & Yield	$3.20 (2.79%)
Beta	0.70

Day Low 114.44115.02 Day High

Close 114.60Open 114.94

News

Jan 14, 2017How to Find Dividend-Hike HeroesBarron's Online
Jan 13, 2017Drug Pricing May Linger Over Biotech in 2017Barron's Online
Jan 7, 2017This Weekend’s Barron’s: Mutual Fund Report for 2016 Fourth Quarter ~ KKR Has Upside of 25% ~ Expedia Is Ready to TakeoffBarron's Online
Dec 22, 2016JNJ-Actelion Deal Could Be Valued at $32 BillionBarron's Online
Dec 20, 2016Gilead Sciences: How Bad is the Glaxo News?Barrons Blogs
Dec 20, 2016Pharma Picks as Fundamentals WeakenBarron's Online
Dec 12, 20163 Barron's Picks Moving Higher, Including J&JBarrons.com
Dec 10, 2016This Weekend’s Barron’s: Dow Rally Has Legs -- 20,000 Next Stop ~ Quarterly Penta Issue ~ Goodyear Poised for a Great Year ~ Insights from the London Hedge Fund ConferenceBarron's Online
Dec 10, 2016J&J Deserves More Respect from Wall Street Barron's Online
Dec 8, 2016Why Biotech is Getting Killed…And Why It WIll Bounce BackBarrons Blogs
Nov 26, 2016Bullish on the Trump MarketBarron's Online
Nov 26, 2016Social-Media Coverage of Stocks Can Be MisleadingBarron's Online
Nov 22, 2016As Medtronic Shares Plunge, This Analyst Says Buy On WeaknessBarrons Blogs
Nov 15, 2016Trump Will Make China Great AgainBarron's Online
Nov 12, 2016Dow Climbs 5.4%, Propelled by Trump’s VictoryBarron's Online
Nov 12, 2016Pharma M&A Is on the WayBarron's Online
Nov 9, 2016Beaten-Up Stocks That Can Beat the MarketBarron's Online
Nov 5, 2016Samsung BioLogics IPO: Too ExpensiveBarron's Online
Oct 25, 2016The Next Big Moves in Health-Care StocksBarron's Online
Oct 22, 201610 Top Dividend Payers for the Long Haul Barron's Online

Loading more news…

There is no more news available.

Jan 16, 2017 8:38 a.m. ETEssilor, Luxottica to Merge, Creating $49 Billion Company -- 4th UpdateDow Jones Newswires
Jan 16, 2017 8:23 a.m. ETRay-Ban Maker Luxottica to Merge With Lens Company Essilor, Creating $49 Billion Eyewear GiantThe Wall Street Journal
Jan 16, 2017 7:10 a.m. ETEssilor, Luxottica to Merge, Creating $49 Billion Company -- 3rd UpdateDow Jones Newswires
Jan 16, 2017 7:07 a.m. ETEssilor, Luxottica to Merge, Creating $49 Billion Company -- 3rd UpdateDow Jones Newswires
Jan 14, 2017Speaking of Dividends: Dividend-Hike Heroes Back to BasicsDow Jones Newswires
Jan 13, 201716 cheap stocks that top investment newsletters say to buy nowMarketWatch.com
Jan 12, 2017Mylan CEO Heather Bresch says caps on drug price increases won’t workMarketWatch.com
Jan 11, 2017What pharma investors ought to do after Donald Trump fires a salvoMarketWatch.com
Jan 11, 2017‘Super Bowl’ of health care has questions about Trump and drug prices, but no answersMarketWatch.com
Jan 10, 2017The Bond Market Is Doing Just Fine, Thank YouWSJ Blogs
Jan 10, 2017Johnson & Johnson to Report Average Increases in List Prices for U.S. DrugsDow Jones Newswires
Jan 10, 2017Johnson & Johnson to Report Average Increases in List Prices for U.S. Drugs The Wall Street Journal
Jan 9, 2017Five unpopular, but prudent, things for investors to do near Dow 20,000MarketWatch.com
Jan 9, 2017Cameron Dallas: Internet Sensation Turned Fashion Star WSJ.com
Jan 9, 2017JPM Healthcare Conference Kicks Off With M&A -- Market TalkDow Jones Newswires
Jan 8, 2017The Fabulous Force in Fashion of @camerondallasThe Wall Street Journal
Jan 6, 2017CES for Marketers: Alexa Wows, Virtual Reality UnderwhelmsThe Wall Street Journal
Jan 4, 2017This techie ‘Dog of the Dow’ is about to get unleashedMarketWatch.com
Jan 4, 2017The Morning Risk Report: With Cybersecurity, It Comes Back to BasicsWSJ Blogs
Jan 2, 2017The Champions of the 401(k) Lament the Revolution They StartedThe Wall Street Journal

Loading more news…

There is no more news available.

Jan 10, 2017Dr. Paul Janssen Award for Biomedical Research Issues 2017 Call for NominationsPR Newswires
Jan 5, 2017( JNJ ) Blog Coverage J&J Bailed Out from $1 Billion Lawsuits, Settled the Claim for About $500 MillionPR Newswires
Jan 3, 2017Johnson & Johnson Announces Quarterly Dividend for First Quarter 2017PR Newswires
Dec 28, 2016( SHPG JNJ ) Blog Coverage Shire Receives FDA Approval for ADYNOVATE for Use in Children Under 12 YearsPR Newswires
Dec 27, 2016Johnson & Johnson to Participate in 35th Annual JP Morgan Health Care ConferencePR Newswires
Dec 27, 2016Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 ResultsPR Newswires
Dec 22, 201620% return on Cisco Systems, or get option-trade ideas on Johnson & Johnson, Mondelez International, The Mosaic Company and Under Armour or any stock you choosePR Newswires
Dec 21, 2016Johnson & Johnson Confirms Exclusive Negotiations with ActelionPR Newswires
Dec 16, 2016Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & JohnsonPR Newswires
Dec 13, 2016Johnson & Johnson Announces it has Ended Discussions with ActelionPR Newswires
Dec 2, 2016Fitbit, bluebird bio Inc., Johnson & Johnson, Skechers, and Diamond Offshore Drilling and more offer option-trading opportunities that offer returns of more than 20%PR Newswires
Dec 1, 2016Dallas Jury Returns $1 Billion-Plus Verdict in Defective DePuy Hip Implants LawsuitPR Newswires
Nov 25, 2016Johnson & Johnson Confirms Discussions with Actelion Regarding Potential TransactionPR Newswires
Nov 16, 2016Johnson & Johnson Establishes Susan L. Lindquist Chair for Women in SciencePR Newswires
Nov 1, 2016Johnson & Johnson Announces Launch of Africa Innovation Challenge to Support Continent's Entrepreneurs and Develop Local Consumer Health SolutionsPR Newswires
Oct 28, 2016Johnson & Johnson Mourns the Loss of Susan Lindquist, Biomedical Research Pioneer and Member of the Johnson & Johnson Board of DirectorsPR Newswires
Oct 26, 2016Johnson & Johnson to Participate in the 25th Annual Credit Suisse Health Care ConferencePR Newswires
Oct 26, 2016Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & JohnsonPR Newswires
Oct 20, 2016Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2016PR Newswires
Oct 20, 2016( JNJ ) Post Earnings Coverage as Johnson and Johnson Profit Soars 27 PercentPR Newswires

Loading more news…

There is no more news available.

Major Holders

Name	Shares Held	% Outstanding	Change in Shares	% of Assets	As Of Date
Vanguard Total Stock Market Index Fund	57.8M	2.13%	779.71K	1.34%	11/30/16
Vanguard 500 Index Fund	38.95M	1.43%	465.43K	1.62%	11/30/16
Vanguard Institutional Index Fund	30.28M	1.11%	160.6K	1.62%	11/30/16
SPDR S&P 500 ETF	30.05M	1.11%	79K	1.63%	11/25/16
Government Pension Fund - Global (The)	23.22M	0.85%	3.01M	0.31%	12/31/15
Fidelity Spartan 500 Index Fund	15.1M	0.56%	119.03K	1.58%	11/30/16
American Funds Washington Mutual Investors	14.36M	0.53%	0	1.93%	10/31/16
SPDR Series - Health Care Select Sector SPDR Fund	13.97M	0.51%	64.33K	11.92%	11/25/16
iShares Core S&P 500 ETF	12.8M	0.47%	42.69K	1.63%	01/4/17
Vanguard Value Index Fund	12.21M	0.45%	176.36K	2.92%	10/31/16

Name	Shares Held	% Outstanding	Change in Shares	% of Assets	As Of Date
The Vanguard Group, Inc.	188.66M	6.94%	4.15M	0.99%	09/30/16
SSgA Funds Management, Inc.	148.67M	5.47%	4.88M	1.6%	09/30/16
BlackRock Fund Advisors	118.14M	4.34%	2.17M	0.95%	09/30/16
Wellington Management Co. LLP	38.3M	1.41%	-799.83K	0.98%	09/30/16
State Farm Investment Management Corp.	37.88M	1.39%	0	6.08%	09/30/16
Northern Trust Investments, Inc.	34.9M	1.28%	-66.23K	1.15%	09/30/16
Fidelity Management & Research Co.	31.96M	1.18%	-5.25M	0.46%	09/30/16
Massachusetts Financial Services Co.	27.72M	1.02%	-544.9K	1.15%	09/30/16
Geode Capital Management LLC	25.65M	0.94%	1.24M	1.29%	09/30/16
Norges Bank Investment Management	24.95M	0.92%	3.36M	0.52%	12/31/15

Name	Shares Held	As Of Date
Wellcome Trust Ltd. (Direct Investments)	1.7M	12/31/16
Alex Gorsky	178.31K	03/1/16
Paulus Stoffels	122.54K	03/1/16
Dominic J. Caruso	116.98K	07/26/16
Michael H. Ullmann	92.92K	03/1/16
Peter M. Fasolo	49.41K	02/8/16
Joaquin Duato	48.5K	04/28/16
Gary J. Pruden	43.73K	06/7/16
Sandra E. Peterson	35.64K	03/1/16
Charles O. Prince	27.32K	10/21/16

Feedback on our new quotes?EMAIL US

Key Stock Data

Shares Outstanding2.72B

Latest Dividend$0.80 (Mar 14, 2017)

Ex-Dividend DateFeb 24, 2017

Institutional Ownership66.96%

Revenue Per Employee$563,525

Short Interest20.29M (12/30/2016)

Short Interest Change+1.54%

Percent of Float0.75%

Net Money Flow$20.1M

Money Flow Ratio1.25%

See Company Financials See Company Ratings

Profile

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development,...

See Company Overview

Key Executives

Alex GorskyChairman & Chief Executive Officer

Dominic J CarusoChief Financial Officer & Vice President

Paulus StoffelsChief Scientific Officer & Executive VP

Sandra E PetersonChairman-Worldwide Group

Gary J PrudenWorldwide Chairman-Global Surgery

Competitors (JNJ)

Symbol	% Chg	Market Cap
GSK	0.538%	$94.8B
NVS	-0.536%	$189.9B
ABT	0.516%	$70.4B
LLY	0.324%	$85.4B
PFE	-0.245%	$197.3B
SYK	-0.276%	$46B
RHHVF	0.331%	$204.8B
SNY	2.093%	$107.2B
MRK	0.209%	$171.9B
MDT	-0.027%	$103.1B

More information on JNJ

Competitor Data Provided By:capital cube